All Stories

  1. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours

    Article • Endocrine, May 2022, Springer Science + Business Media

    Niina Matikainen

  2. Physiology of Calcium Homeostasis

    Article • Endocrinology and Metabolism Clinics of North America, December 2021, Elsevier

    Niina Matikainen

  3. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report

    Article • Frontiers in Endocrinology, June 2021, Frontiers

    Niina Matikainen

  4. Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort

    Article • Endocrine, May 2021, Springer Science + Business Media

    Niina Matikainen

  5. Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes

    Article • Diabetes Obesity and Metabolism, March 2021, Wiley

    Niina Matikainen

  6. Response to Letter on use of functional imaging by 11C-metomidate PET for primary aldosteronism subtyping

    Article • European Journal of Endocrinology, March 2021, Oxford University Press (OUP)

    Niina Matikainen

  7. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

    Article • Arteriosclerosis Thrombosis and Vascular Biology, February 2021, Wolters Kluwer Health

    Niina Matikainen

  8. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans

    Article • JCI Insight, December 2020, American Society for Clinical Investigation

    Niina Matikainen

  9. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism

    Article • European Journal of Endocrinology, December 2020, Oxford University Press (OUP)

    Niina Matikainen

  10. Aldosterone-to-renin ratio is related to arterial stiffness when the screening criteria of primary aldosteronism are not met

    Article • Scientific Reports, November 2020, Springer Science + Business Media

    Niina Matikainen

  11. Primary aldosteronism: Higher volume load, cardiac output and arterial stiffness than in essential hypertension

    Article • Journal of Internal Medicine, June 2020, Wiley

    Niina Matikainen

  12. Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

    Article • Journal of Internal Medicine, January 2020, Wiley

    Niina Matikainen

  13. Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

    Article • Journal of Clinical Lipidology, January 2020, Elsevier

    Niina Matikainen

  14. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

    Article • Nature Communications, September 2019, Springer Science + Business Media

    Niina Matikainen

  15. Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population‐Ascertained Hyperlipidemias

    Article • Journal of the American Heart Association, July 2019, Wolters Kluwer Health

    Niina Matikainen

  16. Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

    Article • Diabetes Obesity and Metabolism, May 2019, Wiley

    Niina Matikainen

  17. Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

    Article • Journal of Internal Medicine, March 2019, Wiley

    Niina Matikainen

  18. Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study

    Article • Diabetes Obesity and Metabolism, September 2018, Wiley

    Niina Matikainen

  19. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

    Article • Cell Metabolism, March 2018, Elsevier

    Sunjae Lee, Niina Matikainen

  20. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors

    Article • Neuroendocrinology, January 2018, Karger Publishers

    Niina Matikainen

  21. Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family

    Article • Atherosclerosis, September 2017, Elsevier

    Niina Matikainen

  22. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

    Article • Journal of Internal Medicine, June 2017, Wiley

    Niina Matikainen

  23. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men

    Article • Nutrition Metabolism and Cardiovascular Diseases, June 2017, Elsevier

    Niina Matikainen

  24. Liver Fat and Insulin Sensitivity Define Metabolite Profiles During a Glucose Tolerance Test in Young Adult Twins

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Professor Jaakko Kaprio, Dr Sakari Jukarainen, Niina Matikainen

  25. The Contribution of GWAS Loci in Familial Dyslipidemias

    Article • PLoS Genetics, May 2016, PLOS

    Niina Matikainen

  26. Adrenal infarction in pregnancy.

    Article • Obstetric Medicine, April 2016, SAGE Publications

    Kalevi Laitinen, Niina Matikainen

  27. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2016, Endocrine Society

    Niina Matikainen

  28. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men

    Article • PLoS ONE, January 2016, PLOS

    Niina Matikainen

  29. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2015, Wolters Kluwer Health

    Niina Matikainen

  30. Circulating makorin ring-finger protein-3 (MKRN3) levels in healthy men and in men with hypogonadotropic hypogonadism

    Article • Clinical Endocrinology, August 2015, Wiley

    Prof Taneli Raivio, Niina Matikainen

  31. Paradoxical Dissociation Between Hepatic Fat Content and De Novo Lipogenesis Due toPNPLA3Sequence Variant

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2015, Endocrine Society

    Niina Matikainen

  32. Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia

    Article • BMC Endocrine Disorders, November 2014, Springer Science + Business Media

    MD, PhD Paloma Almeda-Valdes, Niina Matikainen

  33. Interrelationships Between the Kinetics of VLDL Subspecies and HDL Catabolism in Abdominal Obesity: A Multicenter Tracer Kinetic Study

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2014, Endocrine Society

    Niina Matikainen

  34. Impaired health‐related quality of life in Addison's disease – impact of replacement therapy, comorbidities and socio‐economic factors

    Article • Clinical Endocrinology, June 2014, Wiley

    Niina Matikainen

  35. Amerindian-specific regions under positive selection harbour new lipid variants in Latinos

    Article • Nature Communications, June 2014, Springer Science + Business Media

    Niina Matikainen

  36. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins

    Article • Obesity, May 2014, Wiley

    Niina Matikainen

  37. Postprandial hypertriglyceridemia as a coronary risk factor

    Article • Clinica Chimica Acta, April 2014, Elsevier

    Niina Matikainen

  38. Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue

    Article • January 2014, Elsevier

    Niina Matikainen

  39. GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance

    Article • Diabetes Care, December 2013, American Diabetes Association

    Niina Matikainen

  40. Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects

    Article • PLoS ONE, November 2013, PLOS

    Niina Matikainen

  41. The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

    Article • Diabetic Medicine, May 2013, Wiley

    Niina Matikainen

  42. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci

    Article • Journal of Medical Genetics, March 2013, BMJ

    Niina Matikainen

  43. Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes

    Article • Current Cardiology Reports, September 2012, Springer Science + Business Media

    Niina Matikainen

  44. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity

    Article • Atherosclerosis, May 2012, Elsevier

    Niina Matikainen

  45. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat

    Article • December 2011, Bioscientifica

    Prof Taneli Raivio, Niina Matikainen

  46. Addison's disease presenting as hyperemesis, hyponatremia and pancytopenia in early pregnancy

    Article • Acta Obstetricia Et Gynecologica Scandinavica, November 2010, Wiley

    Niina Matikainen

  47. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome

    Article • Atherosclerosis, July 2010, Elsevier

    Niina Matikainen

  48. PPARα: an emerging therapeutic target in diabetic microvascular damage

    Article • Nature Reviews Endocrinology, June 2010, Springer Science + Business Media

    Niina Matikainen

  49. Reviewing statin therapy in diabetes—Towards the best practise

    Article • Primary Care Diabetes, April 2010, Elsevier

    Niina Matikainen

  50. Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes

    Article • Future Lipidology, January 2008, Taylor & Francis

    Niina Matikainen

  51. Postprandial Lipemia Associates with Liver Fat Content

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2007, Endocrine Society

    Niina Matikainen

  52. The Increase of Apolipoprotein A-V During Postprandial Lipemia Parallels the Response of Triglyceride-Rich Lipoproteins in Type 2 Diabetes

    Article • Diabetes Care, August 2007, American Diabetes Association

    Niina Matikainen

  53. Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

    Article • Diabetologia, July 2006, Springer Science + Business Media

    Niina Matikainen

  54. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes

    Article • Diabetes/Metabolism Research and Reviews, November 2002, Wiley

    Niina Matikainen

  55. Serum C3 but Not Plasma Acylation-Stimulating Protein Is Elevated in Finnish Patients With Familial Combined Hyperlipidemia

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2001, Wolters Kluwer Health

    Niina Matikainen

  56. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease

    Article • Atherosclerosis, May 2000, Elsevier

    Niina Matikainen

  57. Postprandial lipid metabolism in diabetes

    Article • Atherosclerosis, December 1998, Elsevier

    Niina Matikainen

  58. Comparison of three fatty meals in healthy normolipidaemic men: high post‐prandial retinyl ester response to soybean oil

    Article • European Journal of Clinical Investigation, May 1998, Wiley

    Niina Matikainen

  59. Postprandial Elevation of ApoB-48-Containing Triglyceride-Rich Particles and Retinyl Esters in Normolipemic Males Who Smoke

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 1997, Wolters Kluwer Health

    Niina Matikainen

  60. The insulin resistance syndrome and postprandial lipid intolerance in smokers

    Article • Atherosclerosis, February 1997, Elsevier

    Niina Matikainen